RESULTS OF THE DOUBLE-BLIND, RANDOMIZED, MULTICENTER, PHASE III CLINICAL TRIAL OF THYMOGLOBULIN VERSUS ATGAM IN THE TREATMENT OF ACUTE GRAFT REJECTION EPISODES AFTER RENAL TRANSPLANTATION1,2
1998 ◽
Vol 66
(1)
◽
pp. 29-37
◽
Keyword(s):
Keyword(s):
2020 ◽
Vol 101
(9)
◽
pp. 1485-1496
Keyword(s):
2008 ◽
Vol 26
(15_suppl)
◽
pp. 14679-14679
Keyword(s):
2013 ◽
Vol 19
(2)
◽
pp. S137
◽
2015 ◽
Vol 11
(5)
◽
pp. 1094-1102
◽
Keyword(s):
2020 ◽
Vol 202
(4)
◽
pp. 549-557
◽
2007 ◽
Vol 57
(6)
◽
pp. 501
Keyword(s):